BrainsGate
PrivateLast Round
Series F
Dec 6, 2020
Est. Valuation
$161M
Total Funding Raised
$52.5M
Company Overview
BrainsGate operates in Healthcare & Life Sciences and is based in Caesarea. Its latest recorded funding round was a Series F round in December 2020.
BrainsGate is a medical device company that develops implantable neurostimulation therapies for patients suffering from central nervous system diseases, with a primary focus on acute ischemic stroke.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BrainsGate Comparables
Compare BrainsGate with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rapid Medical | 68% | |
| Penumbra | 66% | |
| Medtronic | 65% |
For institutional investors. Book with your work email.
BrainsGate Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series F | Dec 6, 2020 | ||||
| VC Round | Jan 25, 2015 | ||||
| VC Round | Dec 1, 2013 | ||||
| VC Round | Aug 16, 2011 | ||||
| VC Round | Jul 1, 2011 | ||||
Series C | Aug 13, 2008 |
For institutional investors. Book with your work email.
BrainsGate Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Infinity Group | Series A |
| Spero Ventures | Series F |
| Alice Ventures | Seed |
| MB Venture Partners | Series C |
| Cipio Partners | Series F, VC Round |
| Infinity Group | Series C, VC Round |
| Johnson & Johnson Innovation – JJDC | VC Round, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 6, 2020
$14M round led by Spero Ventures.
- Jan 25, 2015
$11M round led by Elron Ventures.
For institutional investors. Book with your work email.
BrainsGate Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BrainsGate's valuation, stock price, and market status.
Is BrainsGate a public or private company?
BrainsGate is a private company.
What is the current stock price of BrainsGate?
BrainsGate is a private company, so its shares have no public market price. Caplight tracks BrainsGate's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BrainsGate worth (valuation)?
BrainsGate's valuation is estimated at $161.0M based on funding round data.
Can I buy BrainsGate stock?
BrainsGate shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BrainsGate's last funding round?
BrainsGate's most recent funding round was Series F on December 6, 2020.
Who are the main investors in BrainsGate?
Key investors in BrainsGate include Spero Ventures, Alice Ventures, Johnson & Johnson Innovation – JJDC, Elron Ventures, Pitango Venture Capital.
Will BrainsGate IPO soon?
No public IPO plans have been announced for BrainsGate.
How can I track BrainsGate secondary market activity?
Caplight tracks bids, offers, and trades in BrainsGate's shares on secondary markets.